FR2615516B1 - Inhibiteurs de la hmg-coa reductase, contenant du phosphore, nouveaux intermediaires de ces inhibiteurs et procede pour leur preparation - Google Patents

Inhibiteurs de la hmg-coa reductase, contenant du phosphore, nouveaux intermediaires de ces inhibiteurs et procede pour leur preparation

Info

Publication number
FR2615516B1
FR2615516B1 FR888806884A FR8806884A FR2615516B1 FR 2615516 B1 FR2615516 B1 FR 2615516B1 FR 888806884 A FR888806884 A FR 888806884A FR 8806884 A FR8806884 A FR 8806884A FR 2615516 B1 FR2615516 B1 FR 2615516B1
Authority
FR
France
Prior art keywords
hmg
preparation
coa reductase
reductase inhibitors
containing phosphorus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR888806884A
Other languages
English (en)
Other versions
FR2615516A1 (fr
Inventor
Donald Steven Karanewsky
Michael Christopher Badia
Scott Adams Biller
Eric Michael Gordon
Michael Joseph Sofia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2615516A1 publication Critical patent/FR2615516A1/fr
Application granted granted Critical
Publication of FR2615516B1 publication Critical patent/FR2615516B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/302—Acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/303—Cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/306—Arylalkanephosphinic acids, e.g. Ar-(CH2)n-P(=X)(R)(XH), (X = O,S, Se; n>=1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3211—Esters of acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3217—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/32—Esters thereof
    • C07F9/3205—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/3241—Esters of arylalkanephosphinic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR888806884A 1987-05-22 1988-05-24 Inhibiteurs de la hmg-coa reductase, contenant du phosphore, nouveaux intermediaires de ces inhibiteurs et procede pour leur preparation Expired - Fee Related FR2615516B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5323887A 1987-05-22 1987-05-22
US10968187A 1987-10-19 1987-10-19

Publications (2)

Publication Number Publication Date
FR2615516A1 FR2615516A1 (fr) 1988-11-25
FR2615516B1 true FR2615516B1 (fr) 1991-04-12

Family

ID=26731613

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888806884A Expired - Fee Related FR2615516B1 (fr) 1987-05-22 1988-05-24 Inhibiteurs de la hmg-coa reductase, contenant du phosphore, nouveaux intermediaires de ces inhibiteurs et procede pour leur preparation

Country Status (24)

Country Link
JP (1) JPH01139589A (fr)
KR (1) KR880013959A (fr)
CN (1) CN1030761A (fr)
AU (2) AU610174B2 (fr)
BE (1) BE1002251A3 (fr)
CH (3) CH675582A5 (fr)
DE (1) DE3817298C2 (fr)
DK (1) DK277388A (fr)
ES (1) ES2009919A6 (fr)
FI (1) FI87927C (fr)
FR (1) FR2615516B1 (fr)
GB (1) GB2205838B (fr)
GR (1) GR880100332A (fr)
HU (1) HU201085B (fr)
IE (1) IE63715B1 (fr)
IL (1) IL86463A (fr)
IT (1) IT1217684B (fr)
NL (1) NL8801331A (fr)
NO (1) NO882219L (fr)
NZ (1) NZ224734A (fr)
PH (2) PH25581A (fr)
PL (1) PL157761B1 (fr)
PT (1) PT87540B (fr)
SE (3) SE501541C2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE503210C2 (sv) * 1987-05-22 1996-04-22 Squibb & Sons Inc Fosforhaltiga HMG- CoA- Reduktasinhibitoret, nya intermediat och sätt
CA2027179A1 (fr) * 1989-10-10 1991-04-11 Barry C. Ross Composes chimiques
US5025000A (en) * 1990-03-02 1991-06-18 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitor compounds
US5124453A (en) * 1990-03-02 1992-06-23 E. R. Squibb & Sons, Inc. Process for preparing certain 5,6,7,8-tetrahydroindolizinyl (ethyl or ethynyl)-hydroxy or methoxy-phosphinyl-3-hydroxy-butanoates and derivatives thereof
CA2042526A1 (fr) * 1990-06-11 1991-12-12 Adeoye Y. Olukotun Methode permettant de prevenir une deuxieme crise cardiaque a l'aide d'un inhibiteur de la hmg coa-reductase
CA2043525A1 (fr) * 1990-06-24 1991-12-25 Donald S. Karanewsky Inhibiteurs de reductase hmg-coa renfermant du phosphore; nouveaux produits intermediaires et methode d'utilisation
DE4023308A1 (de) * 1990-07-21 1992-01-23 Bayer Ag Substituierte pyrido-oxazine
DE4025818A1 (de) * 1990-08-16 1992-02-20 Bayer Ag Phenylsulfonamid substituierte pyridinalken- und -aminooxyalkancarbonsaeure-derivate
NZ241574A (en) * 1991-02-22 1993-08-26 Ishihara Sangyo Kaisha Substituted phenyl derivatives of hydrazone and pesticidal compositions
US5202327A (en) * 1991-07-10 1993-04-13 E. R. Squibb & Sons, Inc. Phosphorus-containing hmg-coa reductase inhibitors
US5256692A (en) * 1992-01-07 1993-10-26 E. R. Squibb & Sons, Inc. Sulfur-containing HMG-COA reductase inhibitors
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
WO2003076409A1 (fr) * 2002-03-14 2003-09-18 Syngenta Participations Ag Derives de 1-phenyl-3-phenylpyrazole utilises comme herbicides
JP4407237B2 (ja) * 2002-12-24 2010-02-03 三菱化学株式会社 非水系電解液及びそれを用いる非水系電解液二次電池
JP4485169B2 (ja) 2003-05-16 2010-06-16 花王株式会社 腸管ミネラル吸収能改善剤
CN1760363B (zh) * 2004-10-14 2010-04-28 蒋继宏 杜仲3-羟基-3-甲基戊二酰辅酶a还原酶蛋白编码序列
TW200736225A (en) * 2006-01-16 2007-10-01 Sankyo Agro Co Ltd A (3-sulfur substituted phenyl) pyrazole derivative

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR339233A (fr) * 1903-12-23 1905-01-26 Cyanidgesellschaft Mit Beschra Nouveau procédé pour l'obtention d'explosifs
DE803645C (de) * 1949-10-11 1951-04-05 Dynamit Act Ges Vormals Alfred Schagwettersichere Sprengkapsel in Verbindung mit elektrischen Zuendern
DE918196C (de) * 1952-12-23 1954-09-20 J G W Berckholtz Fa Masse zur Erzeugung von farbigem Rauch
US3274035A (en) * 1964-06-15 1966-09-20 Lohr A Burkardt Metallic composition for production of hygroscopic smoke
US3862866A (en) * 1971-08-02 1975-01-28 Specialty Products Dev Corp Gas generator composition and method
DE2841815C2 (de) * 1978-09-26 1985-02-21 Buck Chemisch-Technische Werke GmbH & Co, 7347 Bad Überkingen Verfahren zur Herstellung einer Geschoßfüllung
US4438700A (en) * 1982-07-19 1984-03-27 The United States Of America As Represented By The Secretary Of The Army White smoke spotting composition for training ammunition
FR2596393B1 (fr) * 1986-04-01 1988-06-03 Sanofi Sa Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
SE503210C2 (sv) * 1987-05-22 1996-04-22 Squibb & Sons Inc Fosforhaltiga HMG- CoA- Reduktasinhibitoret, nya intermediat och sätt

Also Published As

Publication number Publication date
IE63715B1 (en) 1995-06-14
GB2205838A (en) 1988-12-21
FI87927B (fi) 1992-11-30
PL157761B1 (pl) 1992-06-30
PT87540B (pt) 1992-09-30
DK277388D0 (da) 1988-05-20
AU1650288A (en) 1988-11-24
PH25581A (en) 1991-08-08
FR2615516A1 (fr) 1988-11-25
CH675582A5 (fr) 1990-10-15
FI882385A0 (fi) 1988-05-20
IL86463A (en) 1994-10-07
SE9201588D0 (sv) 1992-05-20
CN1030761A (zh) 1989-02-01
PH26578A (en) 1992-08-19
GB2205838B (en) 1991-12-11
GB8811931D0 (en) 1988-06-22
NO882219D0 (no) 1988-05-20
HUT47123A (en) 1989-01-30
NZ224734A (en) 1991-04-26
GR880100332A (el) 1989-02-23
DE3817298C2 (de) 1997-02-13
CH678625A5 (fr) 1991-10-15
DK277388A (da) 1988-11-23
AU7126691A (en) 1991-05-02
FI882385A (fi) 1988-11-23
AU643501B2 (en) 1993-11-18
SE501541C2 (sv) 1995-03-06
AU610174B2 (en) 1991-05-16
BE1002251A3 (fr) 1990-11-06
IL86463A0 (en) 1988-11-15
CH678626A5 (fr) 1991-10-15
SE8801904D0 (sv) 1988-05-20
HU201085B (en) 1990-09-28
IE881544L (en) 1988-11-22
SE9201588A0 (sv) 1992-05-20
PT87540A (pt) 1989-05-31
SE8801904L (sv) 1988-11-23
IT8820681A0 (it) 1988-05-20
ES2009919A6 (es) 1989-10-16
FI87927C (fi) 1993-03-10
SE9201587D0 (sv) 1992-05-20
KR880013959A (ko) 1988-12-22
NO882219L (no) 1988-11-23
NL8801331A (nl) 1988-12-16
DE3817298A1 (de) 1988-12-01
IT1217684B (it) 1990-03-30
SE9201587A0 (sv) 1992-05-14
JPH01139589A (ja) 1989-06-01

Similar Documents

Publication Publication Date Title
FR2615516B1 (fr) Inhibiteurs de la hmg-coa reductase, contenant du phosphore, nouveaux intermediaires de ces inhibiteurs et procede pour leur preparation
FR2615508B1 (fr) Inhibiteurs de la hmg-coa reductase, contenant du phosphore, nouveaux intermediaires et procedes
MA23880A1 (fr) Amines bicycliques utiles comme insecticides, procede pour leur preparation et compositions les contenant
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
FR2611366B1 (fr) Nouvelles cetones tricycliques utiles comme medicaments, procede et intermediaires pour leur preparation
MA26451A1 (fr) Amides inhibiteurs de secretion de apo b/mtp, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
DZ2729A1 (fr) Composés nouveaux inhibiteurs de nhe-1 procédé pour leur préparation et compositions pharmaceutiquesles contenant.
FR2479208B1 (fr) 2-cyanacrylates, procede pour leur preparation et compositions durcissables contenant ces esters
MA23792A1 (fr) Procede pour la preparation de nouveaux composes
DZ2045A1 (fr) Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
MA26611A1 (fr) Composes heterocycliques nouveaux inhibiteurs de romatases, procede pour leur preparation et compositions pharmaceutiques les contenant
MA21962A1 (fr) Procede pour la preparation d'inhibiteurs de proteass retrovirales .
FR2687687B1 (fr) Procede pour mesurer la taille de fragments d'adn.
MA21148A1 (fr) Procede de preparation de compose b-lactamique et intermediaires pour sa synthese .
PT88364A (pt) Process for preparing novel hmg-coa reductase inhibitors
FR2496461B1 (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxymethylcellulose sodique et nouveaux produits ainsi obtenus
MA22848A1 (fr) Procede enzymatique pour la preparation des aryl-piperidines
FR2560599B1 (fr) Esters phosphoriques et procede pour leur preparation
FR2574075B1 (fr) Procede de synthese d'esters actifs d'acides carboxyliques, nouveaux carbonates alpha-halogenes utiles pour cette synthese et leur mode d'obtention
OA08699A (fr) Aminopropionamides substitués, procédé pour leur préparation, produits les contenat et leur utilisation, ainsi que de nouveaux produit intermediaires pour leur préparation.
MA23651A1 (fr) Spirostanylglycosides cristallins, procede pour leur preparation et compositions les contenant
MA23966A1 (fr) Formes zwitterioniques de trovafloxacine , procede pour leur preparation et compositions les contenant
MA21289A1 (fr) Procede de preparation de nouveaux (w-ammonio acyloxy methylene)-5 tetrahydrofuranes et tetrahydrothiophenes.
FR2644474B1 (fr) Procede de purification d'enzymes

Legal Events

Date Code Title Description
ST Notification of lapse